Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
IPO Year:
Exchange: NASDAQ
Website: optioncarehealth.com
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/30/2025 | $40.00 | Neutral → Buy | UBS |
1/23/2025 | $26.00 → $35.00 | Hold → Buy | Jefferies |
1/13/2025 | $26.00 → $33.00 | Neutral → Buy | BofA Securities |
12/5/2024 | $26.00 | Neutral | UBS |
11/4/2024 | $27.00 | Buy → Neutral | Goldman |
10/31/2024 | $38.00 → $26.00 | Buy → Hold | Jefferies |
10/30/2024 | $43.00 → $29.00 | Buy → Neutral | BofA Securities |
7/16/2024 | $36.00 | Mkt Outperform | JMP Securities |
2/27/2023 | $38.00 | Buy | Jefferies |
8/4/2021 | $22.00 → $24.00 | Buy | Canaccord Genuity |
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
4 - Option Care Health, Inc. (0001014739) (Issuer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
10-Q - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
DEFA14A - Option Care Health, Inc. (0001014739) (Filer)
DEF 14A - Option Care Health, Inc. (0001014739) (Filer)
PRE 14A - Option Care Health, Inc. (0001014739) (Filer)
10-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
8-K - Option Care Health, Inc. (0001014739) (Filer)
SCHEDULE 13G/A - Option Care Health, Inc. (0001014739) (Subject)
UBS upgraded Option Care Health from Neutral to Buy and set a new price target of $40.00
Jefferies upgraded Option Care Health from Hold to Buy and set a new price target of $35.00 from $26.00 previously
BofA Securities upgraded Option Care Health from Neutral to Buy and set a new price target of $33.00 from $26.00 previously
UBS initiated coverage of Option Care Health with a rating of Neutral and set a new price target of $26.00
Goldman downgraded Option Care Health from Buy to Neutral and set a new price target of $27.00
Jefferies downgraded Option Care Health from Buy to Hold and set a new price target of $26.00 from $38.00 previously
BofA Securities downgraded Option Care Health from Buy to Neutral and set a new price target of $29.00 from $43.00 previously
JMP Securities initiated coverage of Option Care Health with a rating of Mkt Outperform and set a new price target of $36.00
Jefferies resumed coverage of Option Care Health with a rating of Buy and set a new price target of $38.00
Canaccord Genuity reiterated coverage of Option Care Health with a rating of Buy and set a new price target of $24.00 from $22.00 previously